Swine Flu: Govt relaxes norms for availability of H1N1 drugs

Drugs were available in restricted number of chemist shops, now will require medical prescription

Swine flu claims 3 more lives in Mumbai; monsoon may aggravate worries
Swine Flu. Representative image: Reuters
Press Trust of India New Delhi
Last Updated : Jul 04 2017 | 4:30 AM IST
Antiviral drugs for treating Swine Flu will soon be available at a chemist shop near you, with the government relaxing norms on their availability.

A recent directive by the Ministry of Health said 'Oseltamivir Phosphate' and 'Zanamivir' drugs have now been included in the Schedule H1 category of the Drugs and Cosmetics Act. Earlier, these drugs belonged to Schedule X category and were available in a restricted number of chemist shops.

The Drug Controller General of India (DCGI) had issued a notice earlier this year revoking its September 15, 2009, notification which had restricted the sale of these drugs for H1N1 as specified under Schedule X.

Patients will now have to produce a medical prescription from a certified doctor to buy the drugs.

Manufacturers of these drugs will have to submit to the DCGI a monthly statement of the quantity of medicines supplied to distributors, stockists, dealers etc.

Besides, pharmacies will have to maintain the sale of such drugs in a separate register for three years.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jul 04 2017 | 4:30 AM IST

Next Story